Effects of 100 mg of Controlled-Release Metoprolol and 100 mg of Atenolol on Blood Pressure, Central Nervous System-Related Symptoms, and General Well Being-Reference-Cited by-同舟云学术

Effects of 100 mg of Controlled-Release Metoprolol and 100 mg of Atenolol on Blood Pressure, Central Nervous System-Related Symptoms, and General Well Being

Published:1994-07 Issue:7 Volume:34 Page:742-747
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Walle Per-O.,Westergren G.,Dimenäs E.,Olofsson B.,Albrektsen T.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1994.tb02034.x/fullpdf

Reference23 articles.

1. Metoprolol: an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders;Benfield;Drugs,1986

2. Controlled release metoprolol formulations: a review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease;Plosker;Drugs,1992

3. Atenolol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders;Wadworth;Drugs,1991

4. Lipophilicity, hydrophilicity and central nervous system side effects of beta-blockers;Drayer;Pharmacotherapy,1987

5. Pharmacologic and physiologic consideration of adrenoceptor blockade;Frohlich;Am J Med,1983

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-independent influence of metoprolol on cardiac and motor functions, QoL, and mental status in Chinese patients with CHF;Therapeutics and Clinical Risk Management;2018-12

2. A prospective study on the impact of heart rate control achieved with metoprolol on cardiac performance, motor function and quality of life in Chinese chronic heart failure patients;International Journal of Cardiology;2017-01

3. Compritol^®888 ATO a Lipid Excipient for Sustained Release of Highly Water Soluble Active: Formulation, Scale-up and IVIVC Study;Current Drug Delivery;2013-08-31

4. Organizzazione aziendale e stress lavoro-correlato: Tutela della salute e sviluppo della performance;Stress e disturbi da somatizzazione;2012

5. Perioperative β-Blockade;Anesthesiology;2011-04-01